Unseen Upside S4:EP3 Precision Oncology & Advancing Personalized Cancer Care

Published on February 12, 2024

Precision oncology represents an exciting shift in cancer treatment from a one-size-fits-all approach to personalized care based on each patient's unique cancer and molecular makeup. In this episode, we'll explore how precision oncology is transforming the landscape of cancer care and improving outcomes at leading hospitals like St. Jude. We'll discuss the latest precision diagnostic technologies enabling doctors to analyze a tumor's molecular profile and match targeted therapies to save lives. Join us as we investigate the promise of precision medicine with Rick Shadyac (St. Jude Children’s Research Hospital); Matt Gevaert (Kiyatec); Jason Robart (Seae Ventures); and Jeff Blazek (Cambridge Associates).

 

Listen to episode three here. 

Other news

Will There be a Second Wave of Inflation?

February 12, 2024
No, we expect Consumer Price Index (CPI) inflation will continue to moderate toward central bank target levels in 2024. As a result, we believe key central banks will cut policy rates modestly this year to avoid overtightening. This should support our view that investors should hold a modest overweight to long Treasury bonds.Read the full publication here.

Unseen Upside S4:EP5 Unlocking the Dark Genome for Lupus & Other Autoimmune Diseases

February 26, 2024
Autoimmune diseases like lupus impact over 5 million patients globally, but treatment options remain limited. Now, decoding the once mysterious "dark genome" could bring new therapies. Over 90% of our DNA was once considered "junk"—but we’ve learned this dark matter regulates gene expression and human disease. This episode takes you to the pioneers who are unlocking the dark genome's potential to